Compare AMRN & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRN | USAU |
|---|---|---|
| Founded | 1989 | 2014 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 283.5M |
| IPO Year | 1993 | N/A |
| Metric | AMRN | USAU |
|---|---|---|
| Price | $14.74 | $16.15 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $22.83 |
| AVG Volume (30 Days) | 80.3K | ★ 418.3K |
| Earning Date | 02-25-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,733,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.08 | $7.38 |
| 52 Week High | $20.90 | $23.75 |
| Indicator | AMRN | USAU |
|---|---|---|
| Relative Strength Index (RSI) | 51.30 | 38.92 |
| Support Level | $14.38 | $15.56 |
| Resistance Level | $15.33 | $17.85 |
| Average True Range (ATR) | 0.74 | 1.16 |
| MACD | -0.02 | -0.34 |
| Stochastic Oscillator | 55.64 | 6.13 |
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.